Korean Circ J.
2018 May;48(5):430-432. 10.4070/kcj.2018.0085.
Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. kikim907@snu.ac.kr
- KMID: 2414912
- DOI: http://doi.org/10.4070/kcj.2018.0085
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Emerging Safety Issues of Dipeptidyl Peptidase-4 Inhibitors and Sodium Glucose Cotransporter 2 Inhibitors: How to Interpret and Apply in Clinical Practice
- Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist)
- Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis
- Dipeptidyl Peptidase 4 Inhibitor, an Update
- Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
